Most Nepalis Hesitate to Start Medicines for Non-Communicable Diseases – Asia News Network

In Nepal, non-communicable diseases (NCDs) like hypertension, diabetes, heart disease, and chronic respiratory illnesses are emerging as major health challenges. Despite the rising prevalence of these conditions, many Nepalis hesitate to initiate prescribed medications promptly. This alarming trend poses significant risks to individual health outcomes and public health in the country. Understanding why this hesitation occurs, its consequences, and how to overcome it is essential both for health professionals and patients alike.

Understanding Non-Communicable Diseases in Nepal

Non-communicable diseases are medical conditions that are not transmitted from person to person. According to the World Health Organization, NCDs account for over 60% of deaths globally, with a large burden placed on developing countries like Nepal. Major NCDs include:

• Cardiovascular diseases (heart attacks, stroke)
• Diabetes
• Chronic respiratory diseases (asthma, chronic obstructive pulmonary disease)
• Cancers

These conditions often require ongoing medication to control symptoms, prevent complications, and improve quality of life. However, the decision to start treatment and maintain adherence can be daunting for many patients.

Why Do Most Nepalis Hesitate to Start Medicines for NCDs?

The hesitation towards starting medicines for non-communicable diseases in Nepal is influenced by various socio-cultural, economic, and systemic factors:

1. Lack of Awareness and Understanding

Many Nepalis are not fully aware of the severity of conditions like hypertension or diabetes if left untreated. There is limited knowledge about the chronic nature of NCDs and the importance of early medication initiation. Misconceptions that symptoms must be visibly severe before starting treatment lead many to delay timely intervention.

2. Fear of Side Effects and Dependency

Concerns about potential medication side effects and fear of becoming “dependent” on medicines cause reluctance among patients. Some believe that continuous medication might weaken their body or cause long-term harm, reflecting a common myth in Nepalese communities.

3. Economic Constraints

The cost of medication and healthcare services can be prohibitive for a large portion of the population. With many people living under the poverty line, the recurring expense of buying medicines deters them from starting or continuing treatment.

4. Cultural Beliefs and Alternative Medicine

Traditional healing practices and Ayurvedic treatments are deeply rooted in Nepali culture. Some patients prefer herbal or alternative remedies over allopathic medicines, hoping to avoid unwanted drug effects or high costs.

5. Accessibility and Healthcare Infrastructure Issues

In rural areas, limited access to healthcare facilities and trained medical professionals hampers early diagnosis and medication initiation. The distance to pharmacies and health centers can discourage regular treatment adherence.

Impact of Delayed Medication on Non-Communicable Diseases

The consequences of hesitation to start treatment for NCDs can be severe:

• Progression of Disease: Untreated conditions often worsen, leading to complications like strokes, kidney failure, or heart attacks.
• Increased Healthcare Costs: Advanced disease stages require more intensive treatments and hospitalizations, inflating both individual and national healthcare expenditures.
• Reduced Quality of Life: Symptoms such as fatigue, breathlessness, and pain increase, limiting daily activities and productivity.
• Higher Mortality Rates: Delays in treatment are closely linked to higher death rates related to non-communicable diseases.

Case Study: Hypertension Medication Hesitation in Kathmandu

A recent study conducted among patients diagnosed with hypertension in Kathmandu found that nearly 45% delayed starting prescribed medication for more than three months after diagnosis. Interviews revealed common reasons, including fear of side effects, assumptions of temporary illness, and financial concerns.

One patient, Mr. Sharma, shared his experience: “I thought high blood pressure was something I could manage with diet and exercise alone. I was scared to take medicines thinking they would damage my liver. It took a health seminar for me to understand the importance of starting treatment early.”

Benefits of Early Medication for Non-Communicable Diseases

Starting medicines promptly after diagnosis can provide many benefits:

• Better Disease Control: Medications help maintain blood pressure, blood sugar, and other parameters within target ranges.
• Prevention of Complications: Early treatment reduces risks of heart attacks, strokes, and organ damage.
• Improved Longevity: Proper management extends life expectancy and physical well-being.
• Smoother Treatment Experience: Health complications and hospitalization incidents decrease, leading to less disruption of daily life.

Practical Tips to Overcome Hesitation and Improve Medication Adherence

For patients and caregivers facing challenges with starting medicines for NCDs, these tips can be extremely helpful:

• Educate Yourself: Learn about your condition from trusted healthcare providers. Understanding the benefits and risks helps reduce unfounded fears.
• Communicate Openly With Doctors: Discuss any concerns, including side effects and costs. Your doctor can adjust medications to suit your needs.
• Start With Small Steps: Incorporate medicines gradually and combine with lifestyle changes like healthy diet and regular exercise.
• Seek Support: Engage family members or patient support groups to encourage adherence and share experiences.
• Access Affordable Medication: Utilize government programs or NGOs offering subsidized medicines to mitigate cost barriers.
• Monitor Your Health: Regular check-ups and self-monitoring foster a sense of control and motivate continued treatment.

Firsthand Experience: A Nepali Patient’s Journey

Sita Devi, a 52-year-old woman from Pokhara, was diagnosed with type 2 diabetes two years ago. Initially, she avoided taking medications due to fear and misinformation. After experiencing dizziness and frequent infections, she sought advice from a local health worker who educated her on the importance of medicines and lifestyle changes.

Sita now takes her medications regularly, follows a balanced diet, and exercises daily. She shares, “Starting medicines was difficult at first because I was scared, but now I feel healthier and more energetic. I wish I had started earlier.”

Role of Media and Healthcare Providers in Raising Awareness

Media outlets like Asia News Network play a crucial role in educating the public on non-communicable diseases and the importance of timely treatment. Coverage that highlights real stories and evidence-based facts can combat myths and stigmas.

Healthcare providers must also:

• Communicate diagnoses and treatment plans clearly and compassionately.
• Provide counseling about medication benefits and possible side effects.
• Follow up with patients to encourage continuous therapy.
• Collaborate with community leaders to integrate traditional beliefs with modern medicine.

Final Thoughts

The hesitation to start medicines for non-communicable diseases among Nepalis is a significant public health concern. Through education, supportive healthcare systems, and community engagement, patients can overcome fears and barriers to medication adherence. Early initiation of treatment not only improves individual health outcomes but also strengthens Nepal’s effort to tackle the growing NCD crisis effectively.